A comparative study of 68GA-FAPI and 18F-FDG PET/CT in diagnosis of nasopharyngeal carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054163

Enrollment

Unknown

Registered

2021-12-10

Start date

2021-12-12

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Gold Standard:Biopsy or surgical pathology diagnosed nasopharyngeal carcinoma.

Index test:FAPI&#32

PET/CT

&#32

FDG&#32

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinically suspected nasopharyngeal carcinoma; 2. Patients suspected of recurrence after treatment of nasopharyngeal carcinoma; 3. Pathological confirmation of nasopharyngeal carcinoma.

Exclusion criteria

Exclusion criteria: 1. Patient has a history of two or more malignant tumors; 2. Patients are unwilling to undergo 68GA-FAPI or 18F-FDG PET/CT imaging.

Design outcomes

Primary

Measure	Time frame
SUVmax (Standardized Uptake Value max);	—

Secondary

Measure	Time frame
Tumor-to-background ratios;	—

Countries

China

Contacts

Public ContactSong Shaoli

Fudan University Shanghai Cancer Center

shaoli-song@163.com+86 18121299622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026